• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Compliance Perspectives: How to Comply with the CMS 60-Day Overpayment Repayment Rule

Compliance Perspectives: How to Comply with the CMS 60-Day Overpayment Repayment Rule

by Glenn S. Demby | Sep 1, 2023 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor

While overpayments may not be your fault, they expose your lab to the risk of liability under the Affordable Care Act.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Medicare Reimbursement: CMS Proposes to Cut Part B Payments to Physicians

Medicare Reimbursement: CMS Proposes to Cut Part B Payments to Physicians

by Glenn S. Demby | Aug 24, 2023 | Essential, National Lab Reporter, Reimbursement-nir

The proposed PFS rule also includes other changes that will affect physician, lab, and other reimbursements in 2024 and beyond.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New CMS TCET Rule Likely Won’t Hasten Medicare Coverage of Breakthrough Devices

New CMS TCET Rule Likely Won’t Hasten Medicare Coverage of Breakthrough Devices

by Glenn S. Demby | Aug 24, 2023 | CMS-nir, Essential, National Lab Reporter

Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
August 2023 FDA Watch

August 2023 FDA Watch

by Glenn S. Demby | Aug 1, 2023 | Essential, FDA-lir, Laboratory Industry Report

Centers for Medicare & Medicaid Services proposes TCET pathway to expedite Medicare Coverage of newly approved breakthrough devices.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Congress Moves to Require Medicare Coverage of Multi-Cancer Early Detection Tests

Congress Moves to Require Medicare Coverage of Multi-Cancer Early Detection Tests

by Glenn S. Demby | Jul 31, 2023 | Essential, Legislation-nir, National Lab Reporter

Federal lawmakers have renewed efforts to pass legislation ensuring Medicare coverage of multi-cancer early detection (MCED) tests.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com